Business
Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th
Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th
About this update from Helix Biopharma Corp.
[{"type":"text","content":"\n\n\n\nNov. 6, 2009 (Canada NewsWire Group) -- AURORA, Ontario, Nov. 6 /CNW/ --Helix BioPharma Corp. (TSX, FSE: \"HBP\" / Pink Sheets: HXBPF) today announced that John Docherty, president and chief operating officer, will present at Merriman Curhan Ford's 6th annual Investor Summit on November 10, 2009 at 4:00 PM at the Sofitel Hotel in New York City. Mr. Docherty will provide an overview of the Company's leading product development programs L-DOS47 and Topical Interferon Alpha-2b. The slide show portion of the presentation will be posted on the Company's website, www.helixbiopharma.com, on November 10th, 2009.About Helix BioPharma Corp.Helix BioPharma Corp. is a biopharmaceutical company specializing in the field of cancer therapy. The Company is actively developing innovative products for the prevention and treatment of cancer based on its proprietary technologies. Helix's product development initiatives include its novel L-DOS47 new drug candidate and its Topical Interferon Alpha-2b. Helix is listed on the TSX and FSE under the symbol \"HBP\" and on the OTCQX International Market under the symbol \"HXBPF.\"About Merriman Curhan FordMerriman Curhan Ford (Nasdaq: MERR) is a financial services firm focused on fast-growing companies and the institutions that invest in them. The company offers high-quality investment banking, equity research, institutional services and corporate & venture services, and specializes in five growth industry sectors: CleanTech, Consumer, Media & Internet, Health Care, Natural Resources and Technology. For more information, please go to www.mcfco.com. For further information contact:Investor RelationsRobert Flamm, Ph.D.Russo Partners LLCTel: (212) 845-4226Email: [email protected] Media RelationsIan StoneRusso Partners LLCTel: (619) 814-3510Fax: (619) 955-5318Email: [email protected] News Release contains certain forward-looking statements and information (collectively, \"forward-looking statements\") regarding the Company's planned presentation at Merriman Curhan Ford's 6th annual Investor Summit and the Company's research and development initiatives, which statements can be identified by the use of forward looking terminology such as \"will\", \"developing\", \"November 10, 2009\", or comparable forward-looking terminology. Helix's actual resul...